ArticleBMC infectious diseases2025
A novel ASXL3 gene variant in a Chinese Boy causing Bainbridge.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
Abstract
backgroundBainbridge-Ropers syndrome (BRPS) is an uncommon genetic disorder characterized by developmental delay, intellectual disability, distinctive facial features, and various congenital anomalies primarily attributed to mutations in the Additional Sex Combs Like 3 (ASXL3) gene. In this case report, we employed Next-Generation Sequencing techniques for genetic analysis to investigate the clinical phenotype, imaging manifestations, and genetic characteristics of BPRS syndrome caused by ASXL3 gene mutation to enhance our understanding of BPRS and its underlying genetic factors. CASE PRESENTATION: This study presents a case of an infant male, aged 4 months and 6 days, who was referred to our hospital with symptoms including fever, cough, and wheezing. The patient had a history of constitutional weakness, previous hospitalizations for respiratory distress, and treatment with continuous positive airway pressure (CPAP). Whole exome sequencing identified a de novo heterozygous ASXL3 gene variant located on chromosome 18 (chr18:31318777-31318779; NM_030632.3; exon 11), described as c.1409_1411delinsTT (p. His470Leufs*14), resulting in a frameshift mutation leading to the diagnosis of BRPS. This variant was classified as pathogenic based on ACMG guidelines.
conclusionTo the best of our knowledge, this variant in the patient has not been reported previously in the literature. This study presents a novel case of the ASXL3 gene variant, emphasizing the significance of genetic analysis in patients with complex clinical presentations. Moreover, it underscores the imperative need for further research on the genetic underpinnings of rare diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.